Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

This phase II study determined response rate of patients with locally advanced or metastatic head and neck cancer treated with pemetrexed disodium, a new multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase and glycinamide ribonucleotide formyl transferase. 35 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Pivot, X, Raymond, E, Laguerre, B, Degardin, M, Cals, L, Armand, J P, Lefebvre, J L, Gedouin, D, Ripoche, V, Kayitalire, L, Niyikiza, C, Johnson, R, Latz, J, Schneider, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364119/
https://www.ncbi.nlm.nih.gov/pubmed/11531245
http://dx.doi.org/10.1054/bjoc.2001.2010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364119/
https://www.ncbi.nlm.nih.gov/pubmed/11531245
http://dx.doi.org/10.1054/bjoc.2001.2010

Ejemplares similares